FREMONT, Calif., Aug. 2, 2016 /PRNewswire/ -- WaferGen
Bio-systems, Inc. (NASDAQ: WGBS) announced today that it will
announce second quarter ended June 30,
2016, financial results after the market close and host a
conference call and webcast on Tuesday,
August 9, 2016.
Conference Call
& Webcast
|
Tuesday, August
9th @ 5pm Eastern:
|
Domestic:
|
877-407-3982
|
International:
|
201-493-6780
|
Conference ID:
|
13642758
|
Webcast:
|
http://public.viavid.com/index.php?id=120672
|
Replays, available
through August 23:
|
Toll-Free:
|
877-870-5176
|
International:
|
858-384-5517
|
Conference ID:
|
13642758
|
About WaferGen
WaferGen Bio-systems, Inc. is a
biotechnology company that offers innovative genomic technology
solutions for single-cell analysis and clinical research. The
ICELL8™ Single-Cell System is a cutting edge platform which can
isolate thousands of single cells and processes specific cells for
analysis, including Next Generation Sequencing ("NGS"). The
system has demonstrated unbiased isolation of up to 1,800 single
cells ranging from 5-100 µm in size on a single chip, including
single cells from solid tumors, brain cells, pulmonary airway
cells, and multiple cell lines. The SmartChip™ platform can
be used for profiling and validating molecular biomarkers, and can
perform massively parallel singleplex PCR for one-step target
enrichment and library preparation for clinical NGS. The
Apollo 324™ system can be used to process DNA and RNA from clinical
samples to NGS-ready libraries. These technologies offer a
powerful set of tools for biological analysis at the molecular and
single cell level in the life sciences, pharmaceutical, and
clinical laboratory industries.
INVESTOR CONTACT:
WaferGen Bio-systems, Inc.
Rollie Carlson
510-277-3417
Rollie.Carlson@wafergen.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/wafergen-bio-systems-to-announce-second-quarter-2016-financial-results-on-tuesday-august-9-300306561.html
SOURCE WaferGen Bio-systems, Inc.